Jobard, E., Blanc, E., Négrier, S., Escudier, B., Gravis, G., Chevreau, C., . . . Trédan, O. (2015). A serum metabolomic fingerprint of bevacizumab and temsirolimus combination as first-line treatment of metastatic renal cell carcinoma. Br J Cancer.

Jobard, Elodie, Ellen Blanc, Sylvie Négrier, Bernard Escudier, Gwenaelle Gravis, Christine Chevreau, Bénédicte Elena-Herrmann, and Olivier Trédan. "A Serum Metabolomic Fingerprint of Bevacizumab and Temsirolimus Combination As First-line Treatment of Metastatic Renal Cell Carcinoma." Br J Cancer 2015.

Jobard, Elodie, et al. "A Serum Metabolomic Fingerprint of Bevacizumab and Temsirolimus Combination As First-line Treatment of Metastatic Renal Cell Carcinoma." Br J Cancer 2015.